Correlation Between Anebulo Pharmaceuticals and OKYO Pharma

Specify exactly 2 symbols:
Can any of the company-specific risk be diversified away by investing in both Anebulo Pharmaceuticals and OKYO Pharma at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Anebulo Pharmaceuticals and OKYO Pharma into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Anebulo Pharmaceuticals and OKYO Pharma Ltd, you can compare the effects of market volatilities on Anebulo Pharmaceuticals and OKYO Pharma and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Anebulo Pharmaceuticals with a short position of OKYO Pharma. Check out your portfolio center. Please also check ongoing floating volatility patterns of Anebulo Pharmaceuticals and OKYO Pharma.

Diversification Opportunities for Anebulo Pharmaceuticals and OKYO Pharma

-0.11
  Correlation Coefficient

Good diversification

The 3 months correlation between Anebulo and OKYO is -0.11. Overlapping area represents the amount of risk that can be diversified away by holding Anebulo Pharmaceuticals and OKYO Pharma Ltd in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on OKYO Pharma and Anebulo Pharmaceuticals is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Anebulo Pharmaceuticals are associated (or correlated) with OKYO Pharma. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of OKYO Pharma has no effect on the direction of Anebulo Pharmaceuticals i.e., Anebulo Pharmaceuticals and OKYO Pharma go up and down completely randomly.

Pair Corralation between Anebulo Pharmaceuticals and OKYO Pharma

Given the investment horizon of 90 days Anebulo Pharmaceuticals is expected to generate 2.06 times more return on investment than OKYO Pharma. However, Anebulo Pharmaceuticals is 2.06 times more volatile than OKYO Pharma Ltd. It trades about 0.02 of its potential returns per unit of risk. OKYO Pharma Ltd is currently generating about 0.02 per unit of risk. If you would invest  180.00  in Anebulo Pharmaceuticals on September 6, 2024 and sell it today you would lose (25.00) from holding Anebulo Pharmaceuticals or give up 13.89% of portfolio value over 90 days.
Time Period3 Months [change]
DirectionMoves Against 
StrengthInsignificant
Accuracy100.0%
ValuesDaily Returns

Anebulo Pharmaceuticals  vs.  OKYO Pharma Ltd

 Performance 
       Timeline  
Anebulo Pharmaceuticals 

Risk-Adjusted Performance

1 of 100

 
Weak
 
Strong
Weak
Compared to the overall equity markets, risk-adjusted returns on investments in Anebulo Pharmaceuticals are ranked lower than 1 (%) of all global equities and portfolios over the last 90 days. Despite somewhat fragile technical and fundamental indicators, Anebulo Pharmaceuticals may actually be approaching a critical reversion point that can send shares even higher in January 2025.
OKYO Pharma 

Risk-Adjusted Performance

1 of 100

 
Weak
 
Strong
Weak
Compared to the overall equity markets, risk-adjusted returns on investments in OKYO Pharma Ltd are ranked lower than 1 (%) of all global equities and portfolios over the last 90 days. In spite of very healthy basic indicators, OKYO Pharma is not utilizing all of its potentials. The current stock price disarray, may contribute to short-term losses for the investors.

Anebulo Pharmaceuticals and OKYO Pharma Volatility Contrast

   Predicted Return Density   
       Returns  

Pair Trading with Anebulo Pharmaceuticals and OKYO Pharma

The main advantage of trading using opposite Anebulo Pharmaceuticals and OKYO Pharma positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Anebulo Pharmaceuticals position performs unexpectedly, OKYO Pharma can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in OKYO Pharma will offset losses from the drop in OKYO Pharma's long position.
The idea behind Anebulo Pharmaceuticals and OKYO Pharma Ltd pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.
Check out your portfolio center.
Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Fundamentals Comparison module to compare fundamentals across multiple equities to find investing opportunities.

Other Complementary Tools

Portfolio Holdings
Check your current holdings and cash postion to detemine if your portfolio needs rebalancing
Content Syndication
Quickly integrate customizable finance content to your own investment portal
Insider Screener
Find insiders across different sectors to evaluate their impact on performance
Equity Forecasting
Use basic forecasting models to generate price predictions and determine price momentum
Portfolio Analyzer
Portfolio analysis module that provides access to portfolio diagnostics and optimization engine